NEW YORK, Nov. 12 – Fluidigm of South San Francisco, Calif., said Monday it had raised $34 million in a round of private financing and has secured commitments for an additional $4 million.

The maker of microfluidics technologies for use on biochips said that it would use the money it raised in the series C financing round to further develop and market its microfluidic pump and valve technology.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.